Sequence Bio
NL - St. John'sBiotechnology
Focus: Sequence Bio is a genomic analysis biotechnology company focused on identifying drug targets for oncology. The company operates as a pre-revenue biotech with a highly specialized, research-driven model.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Sequence Bio?
AI assessmentSequence Bio is a speculative early-stage bet suited only for risk-tolerant scientists seeking deep technical immersion in genomics; career upside depends entirely on company achieving clinical and commercial validation.
Why Work Here
- Early-stage genomics focus positions you at intersection of precision oncology and drug discovery, a high-growth biotech sector
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Open Roles: 1 active job
Hiring Trend
Stable
Help build intelligence for Sequence Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.